As of May 16, 2025, the Utah Medical Products stock's PE ratio is 14.58. This results from the current EPS of $3.78 and stock price of $55.1. The P/E ratio has a decrease of 5% from the past four quarters average of 15.4.
The PE ratio of Utah Medical Products has averaged 22.31 over the last ten years. The current PE ratio of 14.58 is 35% below the historical average. Over the past ten years, UTMD's PE ratio was at its highest in the Jun 2018 quarter at 43.37, when the stock price was $110.15 and the EPS was $2.54. The lowest value was in the Mar 2025 quarter, when it reached 14.83 with a price of $56.04 and an EPS of $3.78.
Maximum annual increase: 62.98% in 2019
Maximum annual decrease: -52.97% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 15.52 | -15.61% | $61.47 | $3.96 |
2023 | 18.39 | -17.12% | $84.22 | $4.58 |
2022 | 22.19 | -10.13% | $100.53 | $4.53 |
2021 | 24.69 | -13.61% | $100 | $4.05 |
2020 | 28.58 | 4.88% | $84.3 | $2.95 |
2019 | 27.25 | 62.98% | $107.9 | $3.96 |
2018 | 16.72 | -52.97% | $83.08 | $4.97 |
2017 | 35.55 | 57.86% | $81.4 | $2.29 |
2016 | 22.52 | 21.53% | $72.75 | $3.23 |
2015 | 18.53 | -6.18% | $58.54 | $3.16 |
2014 | 19.75 | 5.73% | $60.05 | $3.04 |
2013 | 18.68 | 43.58% | $57.16 | $3.06 |
2012 | 13.01 | -1.74% | $36.05 | $2.77 |
2011 | 13.24 | -18.22% | $27 | $2.04 |
2010 | 16.19 | -4.48% | $26.88 | $1.66 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 14.83 | -4.45% | $56.04 | $3.78 |
Dec 2024 | 15.52 | -0.96% | $61.47 | $3.96 |
Sep 2024 | 15.67 | 1.56% | $66.91 | $4.27 |
Jun 2024 | 15.43 | -2.16% | $66.81 | $4.33 |
Mar 2024 | 15.77 | -14.25% | $71.11 | $4.51 |
Dec 2023 | 18.39 | -0.33% | $84.22 | $4.58 |
Sep 2023 | 18.45 | -5.77% | $86 | $4.66 |
Jun 2023 | 19.58 | -2.3% | $93.2 | $4.76 |
Mar 2023 | 20.04 | -9.69% | $94.77 | $4.73 |
Dec 2022 | 22.19 | 14.74% | $100.53 | $4.53 |
Sep 2022 | 19.34 | -1.38% | $85.31 | $4.41 |
Jun 2022 | 19.61 | -8.58% | $85.9 | $4.38 |
Mar 2022 | 21.45 | -13.12% | $89.86 | $4.19 |
Dec 2021 | 24.69 | 2.41% | $100 | $4.05 |
Sep 2021 | 24.11 | -0.5% | $92.84 | $3.85 |
The current PE ratio of UTMD is below the 3, 5 and 10-year averages.
UTMD's PE ratio is lower than its peer stocks JNJ and COO. Utah Medical Products is presently trading at a lower PE ratio (14.58) than its peer group average of 31.8.
Stock name | PE ratio | Market cap |
---|---|---|
UTMD Utah Medical Products Inc | 14.58 | $178.98M |
CNMD CONMED Corp | 15.7 | $1.87B |
JNJ Johnson & Johnson | 16.7 | $364.11B |
TFX Teleflex Inc | 39.66 | $5.71B |
COO Cooper Companies Inc | 39.67 | $16.58B |
MMSI Merit Medical Systems Inc | 47.29 | $5.84B |
The price to earnings ratio for UTMD stock is 14.58 as of May 16, 2025.
As an average over the last 3 years, UTMD stock has a PE ratio of 17.9.
As an average over the last 5 years, UTMD stock has a PE ratio of 20.94.
The highest quarterly PE ratio in the last ten years has been 43.37 and it was in the Jun 2018 quarter.
UTMD's price to earnings ratio is currently 35% below its 10-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 16, 2025), Utah Medical Products's stock price is $55.1. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $3.78. Therefore, Utah Medical Products's P/E ratio for today is 14.58. PE RATIO(14.58) = STOCK PRICE($55.1) / TTM EPS($3.78)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.